- Home
- IFBD vs TOVX Comparison
IFBD vs TOVX Comparison
Compare IFBD & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IFBD
- TOVX
- Stock Information
- Founded
- IFBD 2001
- TOVX 2001
- Country
- IFBD China
- TOVX United States
- Employees
- IFBD N/A
- TOVX N/A
- Industry
- IFBD Computer Software: Prepackaged Software
- TOVX Biotechnology: Pharmaceutical Preparations
- Sector
- IFBD Technology
- TOVX Health Care
- Exchange
- IFBD Nasdaq
- TOVX Nasdaq
- Market Cap
- IFBD 8.4M
- TOVX 3.8M
- IPO Year
- IFBD 2021
- TOVX 2006
- Fundamental
- Price
- IFBD $1.08
- TOVX $0.45
- Analyst Decision
- IFBD
- TOVX Hold
- Analyst Count
- IFBD 0
- TOVX 1
- Target Price
- IFBD N/A
- TOVX N/A
- AVG Volume (30 Days)
- IFBD 23.4K
- TOVX 279.2K
- Earning Date
- IFBD 01-01-0001
- TOVX 08-12-2025
- Dividend Yield
- IFBD N/A
- TOVX N/A
- EPS Growth
- IFBD N/A
- TOVX N/A
- EPS
- IFBD N/A
- TOVX N/A
- Revenue
- IFBD $1,437,848.00
- TOVX N/A
- Revenue This Year
- IFBD N/A
- TOVX N/A
- Revenue Next Year
- IFBD N/A
- TOVX N/A
- P/E Ratio
- IFBD N/A
- TOVX N/A
- Revenue Growth
- IFBD 413.52
- TOVX N/A
- 52 Week Low
- IFBD $0.89
- TOVX $0.40
- 52 Week High
- IFBD $3.54
- TOVX $7.37
- Technical
- Relative Strength Index (RSI)
- IFBD 50.45
- TOVX 37.60
- Support Level
- IFBD $1.02
- TOVX $0.42
- Resistance Level
- IFBD $1.21
- TOVX $0.55
- Average True Range (ATR)
- IFBD 0.06
- TOVX 0.03
- MACD
- IFBD 0.01
- TOVX 0.02
- Stochastic Oscillator
- IFBD 38.10
- TOVX 30.00
About IFBD Infobird Co. Ltd
Infobird Co Ltd is engaged in developing and providing customer engagement cloud-based services. It software-as-a-service provider of AI-powered, or artificial intelligence-enabled, customer engagement solutions in China. It provides holistic software solutions to help corporate clients proactively deliver and manage end-to-end customer engagement activities at all stages of the sales process, including pre-sales and sales activities, and post-sales customer support. It also offers AI-powered cloud-based sales force management software, including intelligent quality inspection and intelligent training software to help clients monitor, benchmark, and improve the performance of agents.
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.